Diabetes, Obesity & Metabolism

Bowel Obstruction/Ileus Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Nationwide Database Study

By Yuichiro Matsuo, Akira Okada, Takashi Sakamoto, Hideo Yasunaga

Cohort study of 298,124 peoplePopulations

The paper

Yuichiro Matsuo, Akira Okada, Takashi Sakamoto, Hideo Yasunaga

The University of Tokyo

Diabetes, Obesity & Metabolism, 9 Aug 2026

doi.org/10.1111/dom.71189 PubMed 42572004

Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes